Table 1. Summary of baseline demographic and disease characteristics (N=41 patients).
| Age, median (range) | |
| Years | 59 (38–76) |
| Gender, n(%) | |
| Male | 22 (54) |
| Female | 19 (46) |
| Performance status, n(%) | |
| 0 | 15 (37) |
| 1 | 25 (61) |
| 2 | 1 (2) |
| Primary tumour type, n(%) | |
| Colorectal | 19 (46) |
| Lung | 3 (7) |
| Pancreas | 2 (5) |
| Bile duct | 2 (5) |
| Cervical | 2 (5) |
| Breast | 2 (5) |
| Anal | 2 (5) |
| Othera | 9 (22) |
| Disease sites at study entry, n(%) | |
| Liver metastases | 27 (66) |
| Lung metastases | 25 (61) |
| Lymph nodes | 21 (51) |
| Peritoneal metastases | 13 (32) |
| Soft tissue | 7 (17) |
| Bone metastases | 3 (7) |
| Otherb | 22 (54) |
| Prior treatment, n(%) | |
| Chemotherapy | 41 (100) |
| No. regimens 1–3 | 24 (59) |
| 4–6 | 15 (37) |
| ⩾7 | 2 (5) |
| Surgery | 33 (80) |
| Radiotherapy | 17 (41) |
a
Lower oesophagus (1), SCC cheek (1), epithelioid mesothelioma (1), GIST (1), ocular melanoma (1), ovary (1), peritoneal carcinoma (1), pleura (1), unknown primary (1).
b
Local recurrence (3), malignant pleural effusion (1), primary tumour (6), other metastases (12).